Experimental vaccination of the Bramleys’ kittens

Experimental vaccination of the Bramleys’ kittens is a small but consequential veterinary episode in which a household’s grief, the limits of available treatment, and a tentative laboratory advance meet. Faced with a highly infectious disease and few effective remedies, James Herriot takes a chance on an experimental vaccine for five kittens belonging to the Bramleys’ valued Topsy line. The delayed report that they have grown into big cats gives the trial its quiet, carefully qualified success.

Outbreak and stakes

The episode begins against a worsening loss. The Bramleys kept cats in considerable numbers and variety, but Herriot had not expected how deeply the family would be affected when the animals began to die. Miss Bramley came to Skeldale House nearly every day with an egg basket holding another sick cat or, at times, several tiny kittens. The basket turns repeated veterinary visits into a visible measure of the outbreak: patients arrive one after another, while the household’s cats diminish.

Herriot’s usual treatment offered little reassurance. Even with modern antibiotics, he observes, Feline panleukopenia (feline infectious enteritis) remains unrewarding to treat; his salicylates and non-specific injections had brought little success. He tried to attend some cats at the surgery, where he could see them several times a day, but the mortality remained high. The effort to help was real, yet the available means did not match the pace or severity of the disease.

The family’s distress also unsettles Herriot’s expectations about farm life. He had assumed that farmers chiefly valued cats as pest killers, but the Bramleys’ grief made clear that these animals mattered to them as more than useful mousers. Miss Bramley’s worn fingers clasping and unclasping the basket handle, and her tears as she faced the prospect of further losses, give that attachment concrete form.

The five kittens and the experimental dose

Miss Bramley identifies the immediate fear: Topsy’s five kittens. They were the best the family had, and Topsy belonged to a line known for ratting and mousing. The kittens were about ten weeks old. Their value to the Bramleys was not abstract; they represented the continuation of a particularly prized strain at the moment when infection threatened the younger cats generally.

There was no protective vaccine available to Herriot. He recalled hearing that Burroughs Wellcome was working on one, and the possibility changed the course of the visit from managing symptoms to testing a still-developing protection. He phoned the Wellcome Laboratory. Rather than dismissing his request, its staff responded cooperatively: they had obtained encouraging results and would provide five doses if he reported what happened. The exact number of doses matched the five kittens, making the proposed trial both sharply limited and directly tied to the family’s concern.

Herriot could promise no outcome. He told Miss Bramley that he had ordered something for the kittens but could not guarantee anything; there was nothing else to do. When the vaccine arrived, he injected the five small animals. Miss Bramley spoke proudly of the Topsy line as he worked, pointing to the kittens’ unusually large ears. Herriot acknowledged their size, and she treated it as a sign of a good mouser. Her attention to this inherited trait places the medical intervention within the family’s own understanding of what made these kittens worth protecting.

A second injection and a long wait

The vaccination was repeated one week later, and the kittens were still looking well at that visit. That observation was encouraging, but it did not yet establish the vaccine’s lasting effect or settle the outcome of the experiment. Herriot told Miss Bramley that they would have to wait and asked her to report back. His request also fulfilled the condition on which the laboratory had supplied the doses: the trial was not simply a treatment offered to one household, but an opportunity to return information about the vaccine’s results.

No report arrived for several months. In the interval, Herriot had almost forgotten the experiment. The delay leaves the outcome suspended beyond the clinical visits themselves: the kittens’ healthy appearance after the second injection is a promising sign, not yet a conclusion. The episode’s account therefore moves from active intervention to an ordinary, prolonged uncertainty, rather than presenting an immediate recovery scene.

The report and its significance

The answer came in a grubby envelope apparently pushed under the surgery door. Miss Bramley’s message was brief, in a careful, spidery hand, and carried no clinical measurements or extended explanation. It said simply that the kittens were now big cats. The statement confirms that the five had lived and grown, and supplies the result Herriot had asked the Bramleys to send to the laboratory.

The note’s plainness is part of the episode’s force. After a sequence marked by repeated deaths, high mortality, and treatments that had achieved little, the report offers a concrete outcome without claiming more than it can show. It supports a successful result for these kittens, but does not establish a broader conclusion about the vaccine’s effectiveness. At the scale of this farm and this family, however, the change is decisive: the threatened Topsy kittens survived into adulthood, and a tentative laboratory advance gave Herriot a way to act when his usual remedies could not.